Bhutan vs East Timor: Access to anti-retroviral drugs, male (%)
Bhutan
62.0%
in 2024
East Timor
62.0%
in 2024
Bhutan rank
94th
East Timor rank
94th
Access to anti-retroviral drugs, male (%) over time
- Bhutan
- East Timor
How they compare
Bhutan currently reports 62.0% against 62.0% in East Timor, a difference of 0.0%.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was East Timor ahead.
Bhutan ranks 94th and East Timor ranks 94th of 141 countries.
Bhutan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bhutan | East Timor | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.6% | 0.6% | 2.0% | Bhutan |
| 2010s | 33.6% | 13.9% | 19.7% | Bhutan |
| 2020s | 58.0% | 53.4% | 4.6% | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Bhutan or East Timor?
- Bhutan, at 62.0% against 62.0% in East Timor as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Bhutan and East Timor?
- 0.0%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and East Timor?
- 22 years are reported by both, from 2000 to 2024.
- How do Bhutan and East Timor rank globally for access to anti-retroviral drugs, male?
- Bhutan ranks 94th and East Timor ranks 94th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.